Novartis (NVS) P/S (1999 - 2026)
Novartis (NVS) P/S from Nov 1, 1999 to Jul 20, 2026. The TTM Novartis (NVS) P/S is 5.11. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Novartis (NVS)
| Year | P/S | Change |
|---|---|---|
| 2026 | 5.11 | +7.93% |
| 2025 | 4.74 | +25.63% |
| 2024 | 3.77 | -13.67% |
| 2023 | 4.37 | +10.87% |
| 2022 | 3.94 | +5.70% |
| 2021 | 3.73 | -13.70% |
| 2020 | 4.32 | -3.14% |
| 2019 | 4.46 | +6.47% |
| 2018 | 4.19 | +4.82% |
| 2017 | 4.00 | +13.38% |
| 2016 | 3.52 | -14.66% |
| 2015 | 4.13 | -2.41% |
| 2014 | 4.23 | +18.87% |
| 2013 | 3.56 | +32.07% |
| 2012 | 2.70 | +13.24% |
| 2011 | 2.38 | -9.02% |
| 2010 | 2.62 | -4.43% |
| 2009 | 2.74 | +3.46% |
| 2008 | 2.65 | -18.33% |
| 2007 | 3.24 | +68.84% |
| 2006 | 1.92 | +6.96% |
| 2005 | 1.79 | +3.84% |
| 2004 | 1.73 | +10.13% |
| 2003 | 1.57 | +24.94% |
| 2002 | 1.26 | +0.63% |
| 2001 | 1.25 | -18.44% |
| 2000 | 1.53 | +22.18% |
| 1999 | 1.25 | N/A |
Comparison Novartis (NVS) P/S with competitors
Novartis (NVS) P/S is 5.11.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -88.75% |
| GRFS | Grifols SA | 0.67 | -86.87% |
| AMRN | Amarin Corp | 1.39 | -72.81% |
| SCLX | Scilex Holding Company | 1.92 | -62.54% |
| SNY | Sanofi | 2.18 | -57.30% |
| PFE | Pfizer Inc | 2.18 | -57.30% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -53.07% |
| BIIB | Biogen Inc | 2.93 | -42.69% |
| GSK | GSK Plc | 3.22 | -36.94% |
| MRK | Merck & Co Inc | 4.54 | -11.27% |
| AZN | Astrazeneca plc | 4.58 | -10.31% |
| AMGN | AMGEN Inc | 5.15 | +0.74% |
| GILD | Gilead Sciences Inc | 5.43 | +6.22% |
| JNJ | Johnson & Johnson | 6.34 | +24.02% |
| ABBV | Abbvie Inc | 7.15 | +39.86% |
| LLY | Lilly(Eli) & Company | 14.28 | +179.33% |